Obiltoxaximab
Hypersensitivity and Anaphylaxis
- Hypersensitivity reactions, including anaphylaxis, have been reported during Infusion
- ANTHIM should be administered in monitored settings by personnel trained and equipped to manage anaphylaxis
- Stop ANTHIM infusion immediately and treat appropriately if hypersensitivity or anaphylaxis occurs
Patient Counseling Information
Package Inserts
Updated April 2016